SYDNEY, AUSTRALIA - 24 September 2024 - Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for ...
Some results have been hidden because they may be inaccessible to you